Contrast-enhanced ultrasonography features of papillary thyroid carcinoma for predicting cervical lymph node metastasis

被引:33
|
作者
Liu, Ying [1 ]
Zhou, Hong [1 ,4 ]
Yang, Peng [2 ]
Zhou, Yang [1 ]
Wu, Jian [3 ]
Chen, Changyu [1 ]
Ye, Ming [1 ]
Luo, Jing [3 ]
机构
[1] Southwest Jiao Tong Univ, Peoples Hosp Chengdu 3, Dept Ultrasound, 82 Qinglong St, Chengdu 610031, Sichuan, Peoples R China
[2] Southwest Jiao Tong Univ, Peoples Hosp Chengdu 3, Dept Pathol, Chengdu 610031, Sichuan, Peoples R China
[3] Southwest Jiao Tong Univ, Peoples Hosp Chengdu 3, Dept Thyroid Surg, Chengdu 610031, Sichuan, Peoples R China
[4] Southwest Jiao Tong Univ, Affiliated Clin Med Coll, 82 Qinglong St, Chengdu 610031, Sichuan, Peoples R China
关键词
contrast-enhanced ultrasonography; papillary thyroid carcinoma; fine needle aspiration; lymph node metastasis; microvascular density; mean intensity ratio of intratumoral/peripheral thyroid parenchyma; ENDOTHELIAL-GROWTH-FACTOR; NECK-DISSECTION; DISTANT METASTASIS; OPTIMAL STRATEGY; RISK-FACTORS; CANCER; PATTERN; MICROCARCINOMA; COMPARTMENT; ANGIOGENESIS;
D O I
10.3892/etm.2017.5087
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study was performed to evaluate the predictive value of contrast-enhanced ultrasonography (CEUS) for the risk of cervical lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC). Between May 2014 and November 2016, 42 patients who received surgery for suspicious PTCs were enrolled in the present study. Each individual underwent CEUS with conventional ultrasound (US), preoperative US-guided fine needle aspiration and personalized surgery. Subsequently, the microvascular density (MVD) of all surgical specimens was measured. According to the results of surgical histopathology, individuals were divided into two groups: LNM+ (PTCs with LNM), and LNM- (PTCs without LNM). Clinicopathological characteristics, CEUS enhancement patterns, perfusion parameters and measurements of MVD were compared. The correlation between quantitative variables and LNM was analyzed using Spearman's correlation analysis. Compared with that in the LNM- group, patients in the LNM+ group were younger (P<0.05) and had a larger mean tumor size (P<0.05). The incidence ratio of patients who were <= 45 years old (P<0.05), tumors >10 mm in size (P<0.05) and capsular infiltration (P<0.05) were statistically higher in the LNM+ group. Following the use of a novel classification system, the ratio of PTCs with early partial hyper-enhancement was identified to be significantly higher in the LNM+ group (P<0.01). The mean intensity, intensity increase velocity, MVD ratio and mean intensity ratio of intratumoral/periphe-ral thyroid parenchyma (MIR) were statistically higher in the LNM+ group compared with that in the LNM-group (all P<0.05). MIR was identified to be positive correlated with LNM (P<0.05). A MIR value of 0.86 was the optimal threshold of LNM in PTCs. In conclusion, LNM may rely on the local rich blood supply of PTC lesions. Partial hyper-enhancements of CEUS and higher values of MIR may suggest a high risk for LNM in PTC.
引用
收藏
页码:4321 / 4327
页数:7
相关论文
共 50 条
  • [21] Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study
    Zhixin Yang
    Xiaofeng Wang
    Tao Tao
    Jiali Zou
    Zhu Qiu
    Long Wang
    Huimin Du
    Ni Chen
    Xuedong Yin
    BMC Surgery, 23
  • [22] Dynamic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma
    Zhuo, Xianhua
    Yu, Jiandong
    Chen, Zhiping
    Lin, Zeyu
    Huang, Xiaoming
    Chen, Qin
    Zhu, Hongquan
    Wan, Yunle
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 166 (03) : 444 - 453
  • [23] Effectiveness of Lymphatic Contrast Enhanced Ultrasound in the diagnosis of Cervical Lymph node metastasis from papillary thyroid carcinoma
    Wei, Ying
    Niu, Yun
    Zhao, Zhen-long
    Cao, Xiao-jing
    Peng, Li-li
    Li, Yan
    Yu, Ming-an
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Diagnostic value of contrast-enhanced ultrasonography in the preoperative evaluation of lymph node metastasis in papillary thyroid carcinoma: a single-center retrospective study
    Yang, Zhixin
    Wang, Xiaofeng
    Tao, Tao
    Zou, Jiali
    Qiu, Zhu
    Wang, Long
    Du, Huimin
    Chen, Ni
    Yin, Xuedong
    BMC SURGERY, 2023, 23 (01)
  • [25] Effectiveness of Lymphatic Contrast Enhanced Ultrasound in the diagnosis of Cervical Lymph node metastasis from papillary thyroid carcinoma
    Ying Wei
    Yun Niu
    Zhen-long Zhao
    Xiao-jing Cao
    Li-li Peng
    Yan Li
    Ming-an Yu
    Scientific Reports, 12
  • [26] Conventional ultrasound combined with contrast-enhanced ultrasound predicts lateral lymph node metastasis in papillary thyroid carcinoma
    Lu, Jing
    Wu, Xiaofeng
    Wang, Wei
    Chen, Zhiming
    Jin, Chenyang
    Zhao, Dan
    Zhang, Kairen
    Dong, Fenglin
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2025, 89 (01) : 83 - 94
  • [27] Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma
    Xiao, Lingli
    Zhou, Jianhua
    Tan, Wen
    Liu, Ying
    Zheng, Haoming
    Wang, Guanying
    Zheng, Wei
    Pei, Xiaoqing
    Yang, Ankui
    Liu, Longzhong
    RADIOLOGY, 2023, 307 (04)
  • [28] Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy
    Zhan, Jia
    Diao, Xuehong
    Chen, Yue
    Wang, Wenping
    Ding, Hong
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2019, 72 (01) : 61 - 73
  • [29] Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma
    Feng, Y.
    Min, Y.
    Chen, H.
    Xiang, K.
    Wang, X.
    Yin, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (10) : 2203 - 2211
  • [30] Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma
    Y. Feng
    Y. Min
    H. Chen
    K. Xiang
    X. Wang
    G. Yin
    Journal of Endocrinological Investigation, 2021, 44 : 2203 - 2211